Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + Corticosteroids
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Kidney Transplantation
Conditions
Kidney Transplantation
Trial Timeline
Feb 1, 2008 → Feb 1, 2011
NCT ID
NCT00543569About Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + Corticosteroids
Alefacept + tacrolimus + basiliximab + mycophenolate mofetil + Corticosteroids is a phase 2 stage product being developed by Astellas Pharma for Kidney Transplantation. The current trial status is completed. This product is registered under clinical trial identifier NCT00543569. Target conditions include Kidney Transplantation.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00543569 | Phase 2 | Completed |
Competing Products
20 competing products in Kidney Transplantation